New Version of ADapt Available from MediciGlobal
MediciGlobal (Philadelphia and London) has released a new version of ADapt, its Web-based system that customizes patient recruitment materials based on a study's geography. Since being introduced in early 2008, over 235 users have employed the system to translate patient materials, linguistically adapt them, and initiate the IRB submissions process.
"The power of this system is that we're pushing patient recruitment down to the local level and achieving this faster than conventional methods," says Liz Moench, MediciGlobal's President and Chief Executive Officer.
"ADapt brings speed, quality, localization, and local team buy-in, and all this is achieved more cost effectively."
What users can expect from the latest version of ADapt are faster operating times and paperless Ethics/IRB submission and approval tracking. Other enhancements include:
- Increased project communications between users in the field (CRAs, site staff, translators, recruitment specialists) and study sponsors
- More detailed tracking of materials in development, by country, language and specific editorial changes right down to each specific document
- Increased sponsor management of the project's overall development process
- User activity management to ensure tasks are completed and project timelines are kept on track.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
